The FDA put a partial clinical hold on a Phase 3 trial of an anti … Endpoints News. Sign up to read this article for free. Get free access …
FDA partially holds BioNTech’s Phase 3 anti-CTLA-4, company pauses enrollment
Share This Story, Choose Your Platform!
About the Author:
